TY  - JOUR 
AU  - Creedon, Helen
AU  - Gómez Cuadrado, Laura
AU  - Tarnauskaitė, Žygimantė
AU  - Balla, Jozef
AU  - Canel, Marta
AU  - MacLeod, Kenneth G.
AU  - Serrels, Bryan
AU  - Fraser, Craig
AU  - Unciti-Broceta, Asier
AU  - Tracey, Natasha
AU  - Le Bihan, Thierry
AU  - Kilnowska, Teresa
AU  - Sims, Andrew H.
AU  - Byron, Adam
AU  - Brunton, Valerie G.
PY  - 2016
UR  - http://hdl.handle.net/10259/9792
AB  - Resistance to human epidermal growth factor receptor 2 (HER2)-targeted therapies in the treatment of HER2-positive breast cancer is a major clinical problem. To identify pathways linked to resistance, we generated HER2-positive breast cancer cell...
LA  - eng
PB  - Impact Journals
KW  - Resistance
KW  - Breast cancer
KW  - EMT
KW  - HER2
KW  - Proteomics
KW  - Salud
KW  - Health
KW  - Medicina
KW  - Medicine
KW  - Oncología
KW  - Oncology
TI  - Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy
DO  - 10.18632/oncotarget.7317
T2  - Oncotarget
VL  - 7
M2  - 11539
ER  -